INTRODUCTION: Human immunodeficiency virus (HIV) coinfection with Leishmania infantum or Leishmania donovani, the agents of visceral leishmaniasis (or kala-azar), has become a fatal public health problem in the tropics where kala-azar is endemic. METHODS: The clinical presentation of patients with HIV and L. infantum coinfection is described using two unique databases that together produce the largest case series of patients with kala-azar infected with HIV in South America. First, a retrospective study paired the list of all patients with kala-azar from 1994 to 2004 with another of all patients with HIV/AIDS from the reference hospital for both diseases in the City of Teresina, State of Piauí, Brazil. Beginning in 2005 through to 2010 this information was prospectively collected at the moment of hospitalization. RESULTS: During the study, 256 admissions related to 224 patients with HIV/L. infantum coinfection were registered and most of them were males between 20-40 years of age. Most of the 224 patients were males between 20-40 years of age. HIV contraction was principally sexual. The most common symptoms and signs were pallor, fever, asthenia and hepatosplenomegaly. 16.8% of the cohort died. The primary risk factors associated to death were kidney or respiratory failure, somnolence, hemorrhagic manifestations and a syndrome of systemic inflammation. The diagnosis of HIV and kala-azar was made simultaneously in 124 patients. CONCLUSIONS: The urban association between HIV and kala-azar coinfection in South America is worrisome due to difficulty in establishing the diagnosis and higher mortality among the coinfected then those with either disease independently. HIV/L. infantum coinfection exhibits some singular characteristics and due to its higher mortality it requires immediate assistance to patients and greater research on appropriate combination therapy.
INTRODUCTION: Human immunodeficiency virus (HIV) coinfection with Leishmania infantum or Leishmania donovani, the agents of visceral leishmaniasis (or kala-azar), has become a fatal public health problem in the tropics where kala-azar is endemic. METHODS: The clinical presentation of patients with HIV and L. infantum coinfection is described using two unique databases that together produce the largest case series of patients with kala-azar infected with HIV in South America. First, a retrospective study paired the list of all patients with kala-azar from 1994 to 2004 with another of all patients with HIV/AIDS from the reference hospital for both diseases in the City of Teresina, State of Piauí, Brazil. Beginning in 2005 through to 2010 this information was prospectively collected at the moment of hospitalization. RESULTS: During the study, 256 admissions related to 224 patients with HIV/L. infantum coinfection were registered and most of them were males between 20-40 years of age. Most of the 224 patients were males between 20-40 years of age. HIV contraction was principally sexual. The most common symptoms and signs were pallor, fever, asthenia and hepatosplenomegaly. 16.8% of the cohort died. The primary risk factors associated to death were kidney or respiratory failure, somnolence, hemorrhagic manifestations and a syndrome of systemic inflammation. The diagnosis of HIV and kala-azar was made simultaneously in 124 patients. CONCLUSIONS: The urban association between HIV and kala-azar coinfection in South America is worrisome due to difficulty in establishing the diagnosis and higher mortality among the coinfected then those with either disease independently. HIV/L. infantum coinfection exhibits some singular characteristics and due to its higher mortality it requires immediate assistance to patients and greater research on appropriate combination therapy.
Authors: Diego Lins Guedes; Zulma Medeiros; Elis Dionísio da Silva; Audrey Violeta Martins de Vasconcelos; Mariana Santana da Silva; Maria Almerice Lopes da Silva; Paulo Sérgio Ramos de Araújo; Demócrito de Barros Miranda-Filho Journal: Am J Trop Med Hyg Date: 2018-12 Impact factor: 2.345
Authors: Luis G C Reinaldo; Raimundo J C Araújo-Júnior; Thiago M Diniz; Rafael D Moura; Antônio J Meneses-Filho; Caio V V M Furtado; Washington L C Santos; Dorcas L Costa; Kelsen D Eulálio; Gabriel R Ferreira; Carlos H N Costa Journal: Am J Trop Med Hyg Date: 2022-06-20 Impact factor: 3.707
Authors: Angelita F Druzian; Albert S de Souza; Diogo N de Campos; Julio Croda; Minoru G Higa; Maria Elizabeth C Dorval; Mauricio A Pompilio; Polliana A de Oliveira; Anamaria M M Paniago Journal: PLoS Negl Trop Dis Date: 2015-08-14
Authors: Daniel Holanda Barroso; Claúdia Elise Ferraz Silva; Ana Carolina Depes Perdigao e Vasconcelos; Silvana Maria de Morais Cavalcanti; Maria Edileuza Felinto de Brito; Angela Cristina Rapela Medeiros Journal: An Bras Dermatol Date: 2015 May-Jun Impact factor: 1.896
Authors: José Angelo Lindoso; Gláucia Fernandes Cota; Alda Maria da Cruz; Hiro Goto; Ana Nilce Silveira Maia-Elkhoury; Gustavo Adolfo Sierra Romero; Márcia Leite de Sousa-Gomes; Joanna Reis Santos-Oliveira; Ana Rabello Journal: PLoS Negl Trop Dis Date: 2014-09-18
Authors: José Angelo Lauletta Lindoso; Mirella Alves Cunha; Igor Thiago Queiroz; Carlos Henrique Valente Moreira Journal: HIV AIDS (Auckl) Date: 2016-10-07
Authors: José Angelo Lauletta Lindoso; Carlos Henrique Valente Moreira; Mirella Alves Cunha; Igor Thiago Queiroz Journal: HIV AIDS (Auckl) Date: 2018-10-15
Authors: Uiara Regina Silva de Lima; Luciano Vanolli; Elizabeth Coelho Moraes; Jorim Severino Ithamar; Conceição de Maria Pedrozo E Silva de Azevedo Journal: PLoS One Date: 2019-12-05 Impact factor: 3.240